
    
      To identify the molecular and cellular targets of MCS treatment and determine the mechanistic
      relationship to airways remodelling in patients with chronic bronchitis. Phenotype,
      characterise and correlate clinical, physiological, histological and molecular parameters in
      patients with chronic bronchitis.
    
  